CTAS
37
-5
UPS
55
-5
PG
41
3
UHS
50
-18
TXN
50
-15
MMM
56
4
LNC
56
3
LEN
28
-4
RL
68
-2
CCL
64
3
XEL
51
-27
DLTR
63
-5
OI
58
2
DVA
39
3
PHM
54
-4
EXR
37
-14
SO
53
-9
XRX
34
-22
C
64
3
HBAN
56
-11
CTAS
37
-5
UPS
55
-5
PG
41
3
UHS
50
-18
TXN
50
-15
MMM
56
4
LNC
56
3
LEN
28
-4
RL
68
-2
CCL
64
3
XEL
51
-27
DLTR
63
-5
OI
58
2
DVA
39
3
PHM
54
-4
EXR
37
-14
SO
53
-9
XRX
34
-22
C
64
3
HBAN
56
-11
Financhill
Back

Immunovant, Inc. Stock Predictions

99.6% Win Rate Across 508 Picks (Third-Party Audited)

See how Decentralized Masters' system identifies 10x-100x opportunities before Coinbase. Watch free training.
Sell
34

IMVT
Immunovant, Inc.

Last Price:
$26.01
Seasonality Move:
-30.89%

7 Day Trial

ALL ACCESS PASS

$ 7

Coinbase Lost $400M. Your Crypto Isn't Safe on Exchanges.

Stop trusting exchanges. Learn how to access Native Markets where YOU control your assets

Immunovant, Inc. Stock Forecast

  • Over the next 52 weeks, Immunovant, Inc. has on average historically risen by 51.3% based on the past 6 years of stock performance.
  • Immunovant, Inc. has risen higher in 4 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is Immunovant, Inc. Stock Undervalued?
    The current Immunovant, Inc. [IMVT] share price is $26.18. The Score for IMVT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • IMVT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Immunovant, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, Immunovant, Inc. has on average historically risen by 51.3% based on the past 6 years of stock performance.

Immunovant, Inc. Stock Rating

Sell
34
Immunovant, Inc. (IMVT) is a Sell

Is Immunovant, Inc. overpriced?

  • Immunovant, Inc. has risen higher in 4 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Immunovant, Inc. Stock Price History

Is IMVT stock going to rise?

  • The current trend is moderately bullish and IMVT is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
immunovant.com

52-Week Data

52-Week High:
27.80
52-Week Low:
12.72

Prediction Charts

Market Cap:
4.6B
Price in USD:
26.18
Volume:
1.6M
Beta:
0.76

Technical Analysis

SMA50:
24.83
SMA100:
21.30
SMA200:
18.47
52-Wk Change:
12.7%

Stock Predictions

  • Is Immunovant, Inc. stock public?
    Yes, Immunovant, Inc. is a publicly traded company.
  • What is the Immunovant, Inc. stock quote today?
    The Immunovant, Inc. stock price is 26.18 USD today.
  • How to buy Immunovant, Inc. stock online?
    You can buy Immunovant, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-31 25.32 25.42 25.71 25.05
Jan-5 25.78 24.97 25.90 24.70
Jan-6 25.83 25.90 26.39 24.98
Jan-7 26.05 26.73 27.38 25.90
Jan-8 26.32 26.31 26.62 25.78
Jan-9 26.67 26.03 27.80 26.00
Jan-12 26.04 25.81 26.22 25.37
Jan-13 25.76 26.18 26.41 25.18
Jan-14 26.08 27.35 27.37 25.70
Jan-15 27.33 26.00 27.34 25.58
Jan-16 25.62 26.27 26.60 25.61
Jan-20 25.72 26.14 26.47 25.43
Jan-21 26.03 26.02 26.69 25.98
Jan-22 25.99 26.18 26.56 25.85

Immunovant, Inc. Earnings

Immunovant, Inc. Earnings Report: Per Share Immunovant, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Immunovant, Inc. Forecast Revenue Growth

Immunovant, Inc. Stock Analysis: Historical quarterly revenues per share for Immunovant, Inc. and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.07 per share.

* Immunovant, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.